acquisition

AbbVie’s earnings will likely drop 20% in 2023 as its main drug, Humira, faces new competition in the U.S. from generics. However, the company has several promising drugs in its development pipeline that should spur its revenue and earnings for years to come. That should let AbbVie keep raising your dividend, as it has done each year since becoming a separate firm in 2013.


ABBVIE INC....

GANNETT CO. INC. $2.58 remains a hold. The company (New York symbol GCI; Conservative-Growth Portfolio, Consumer sector: Shares outstanding: 146.1 million; Market cap: $376.9 million; Price-to-sales ratio: 0.1; Dividend suspended in 2020; TSINetwork Rating: Speculative; www.gannett.com) merged with GateHouse Media, and its parent company New Media Investment Group Inc....

Drugmaker Eli Lilly has two potentially huge blockbuster drugs on the horizon—one for obesity, the other for Alzheimer’s. But even without these two, the company’s future is bright given the strength of its existing roster of drugs plus new drugs in its pipeline.

The stock is up 108.4% since we first recommended it in our June 2020 issue of Power Growth Investor at $157.19....

ZIMMER BIOMET HOLDINGS INC., $125.97, symbol ZBH on New York, manufactures orthopedic reconstructive implants and surgical equipment for orthopedic surgeries. Zimmer has the largest market share for reconstructive implants in the U.S.

In March 2022, the company spun off its Spine and Dental businesses as ZimVie Inc....

CANADIAN TIRE CORP., $174.64, Toronto symbol CTC.A, is a top pick for 2023.

Investors benefit from the company’s 504 Canadian Tire stores. They sell automotive parts and services, and household and sporting goods; franchisees run most of the locations....

GEN DIGITAL INC., $21.53, is a buy. The company (Nasdaq symbol GEN; TSINetwork Rating: Extra Risk) (gendigital.com; Shares o/s: 661.0 million; Market cap: $14.2 billion; Divd....

We think the healthcare industry will enjoy great success over the next decade. But due to the nature of the business, results will vary widely and unpredictably from one company to another. A volatile market like the one we expect for healthcare stocks will include winners and losers....

Alimentation Couche-Tard has moved to add more car washes to its portfolio as a way of boosting new and existing revenue. Car washes not only add standalone value, but also let the company cross-sell the services of its convenience stores and gas-stations.


ALIMENTATION COUCHE-TARD, $64.37, is a #1 Power Buy for your 2023 investing. The company (Toronto symbol ATD; TSINetwork Rating: Average) (couchetard.com; Shares o/s: 1.0 billion; Market cap: $64.4 billion; Dividend yield: 0.9%) recently added to its chain of car washes with the acquisition of True Blue Car Wash LLC, which has 65 locations in high-traffic areas of Arizona, Illinois, Indiana and Texas....

TRISURA GROUP LTD. $38 remains a buy for aggressive investors. The company (Toronto symbol TSU; Finance Sector; Shares outstanding: 45.8 million; Market cap: $1.7 billion; No dividend paid; Takeover Target Rating: Medium; www.trisura.com) took its current form on June 22, 2017 when Brookfield Asset Management Inc....

In 2019, the old DowDuPont (New York symbol DWDP) split itself into three separate, more-focused companies—DuPont, Dow and Corteva.


All three are up since the split, as investors prefer pure-play companies over conglomerates that hold a variety of businesses....